Matthew Klein

Matthew Klein

Company: PTC Therapeutics

Job title: Chief Development Officer


Designing Clinical Trials for Mitochondrial Disease Therapies 10:00 am

Understanding how drug development for mitochondrial disease is fraught with challenges due to disease heterogeneity, lack of comprehensive natural history and lack of precedent of approved therapies to guide development Examining how careful consideration of inclusion criteria to minimize heterogeneity and enrich study participants will be most likely to respond to a therapeutic intervention which…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.